Connecting with you to meet your pressure ulcer challenges

Prevention is more cost effective than ever

Pressure ulcers - the most frequent type of expensive, avoidable side-effect of care has been estimated to cost a facility $10,288 per occurrence. The total cost of managing a Medicare patient with a pressure ulcer in acute care averages $43,180.00 per hospital stay1 and many healthcare facilities are ceasing to cover the cost of hospital-acquired pressure ulcers (HAPU2).
Adding a dressing to your prevention programme may help you to reduce your HAPU costs by helping them stop before they start.

Recommended products: Mepilex Border Sacrum, Mepilex Border and Mepilex

The importance of a comprehensive prevention program

Your pressure ulcer prevention protcol is already robust and includes key elements...

The Problem

HAPU occur most commonly in the ICU (12-42%)3, with the rate of interoperatively acquired HAP ranging from 12% to 66% in surgical patients...

Dressings for prevention

Mepilex® Border Sacrum can add to your HAPU prevention programme by redistributing shear forces...

The power of four

When compared with no dressing and competitors’ products...

NEW! Download the new consensus document

About pressure ulcers

The importance of a comprehensive pressure ulcer prevention programme

Your pressure ulcer prevention protocol is already robust and includes key elements such as risk assessment, regular positioning, selecting appropriate pressure redistribution and support surfaces, but an emerging strategy is to add to this programme utilising protective dressing such as Mepilex® Border as part of the prevention programme.

Read more in the consensus statement which you can download here.

Application tools

Mepilex Border Heel Application Guide

Mepilex Border Sacrum Application Guide


Pressure ulcers

A pressure ulcer may be defined as a “localised injury to the skin and/or underlying tissue, usually over a bony prominence, as a result of pressure or pressure in combination with shear. A number of contributing or confounding factors are also associated with pressure ulcers; the significance of these factors has yet to be elucidated1”.

Prevalence and incidence are well reported in the literature and vary according to care specialty; for example, it is often reported to be higher in specific specialties such as critical care or elderly care, with the sacrum and heel the most commonly affected body locations.

Apart from causing pain and distress for your patient, pressure ulcers also place a major burden on healthcare systems worldwide, through increased needs for nursing time, hospitalisation, consumables and pharmaceuticals. For example the annual cost of pressure ulceration in the UK National Health Service is estimated at £1.4–£2.1 billion annually, which is 4 % of the service’s total expenditure15.

Paying close attention to the actual challenges for healthcare professionals, we have implemented a comprehensive therapeutic approach to pressure ulcer prevention– ranging from listening too health care professionals and instigating discussions and education opportunities, to performing research and developing state of the art products. Mepilex Border is one of the products that are widely used to treat and prevent pressure ulcers today.


1. Walsh, N. et al. Pressure Ulcer Prevention of Stage 2 and Deep Tissue Injury in Critical Care: A Pilot Study. Poster presentation at the WOCN Congress, 2011.
2. Padula, W. et al. Improving the Quality of Pressure Ulcer Care With Prevention, A Cost-Effectiveness Analysis. Medical Care 2011; 49(4).

Share this